Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122381) titled 'A Clinical Study of Camrelizumab in Combination with Albumin-Bound Paclitaxel and Cisplatin as Adjuvant Therapy for Locally Advanced Esophageal Squamous Cell Carcinoma after Surgery' on April 13.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: The First Affiliated Hospital of Anhui Medical University
Condition:
Esophageal cancer
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-04-13
Target Sample Size: Test group:60;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=317720
Published by HT Digital...